[Complications of intermittent rifampicin treatment. Role of immuno-allergic factors. Study of 8 cases].
D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000517:prevention & control; D006461:Hemolysis; D006801:Humans; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D012293:Rifampin
Accidents des traitements intermittents par la rifampicine. Rôle des facteurs immuno-allergiques. Etude de 8 cas